Document is current
Any future updates will be listed below
-
Authors
Bach, Megan
Kassab, Joseph
Mohamed Hassan, Ahmed https://orcid.org/0000-0001-9605-1539
Kodur, Nandan
Laffin, Luke J. https://orcid.org/0000-0002-3262-792X
- License Information
-
More Information
Article History
Received: 27 January 2025
Revised: 14 May 2025
Accepted: 23 May 2025
First Online: 30 May 2025
Competing interests
: There are no conflicts of interest related to this manuscript. Dr. Laffin has been a consultant and/or served on steering committees for AstraZeneca, Crispr Therapeutics, Eli Lilly, Idorsia, Kardigan, Medtronic, Mineralys Therapeutics, Novo Nordisk, Recor, Ripple Medical, and Stability Health; has received research funding from AstraZeneca. The other authors have no disclosures.
